Dan Benjamin Teleman

Chief Executive Officer at Nasus Pharma Ltd.

Sits on 1 board. Last updated September 28, 2026

Time on boards

Boards served
1
Current seats
1
Board service
7 months
Director since
2026

7 months of board service in total across 1 board, counting each seat separately. Longest: Nasus Pharma Ltd., 7 months.

Nasus Pharma Ltd. Director · Chief Executive Officer
7 months · Since 2026

Chief executive roles

Nasus Pharma Ltd. · Chief Executive Officer
2026 – 2026 · Former

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Jun 17, 2026 Nasus Pharma Ltd. Open-market purchase +6,550 $3.10 $20,305
Apr 22, 2026 Nasus Pharma Ltd. Open-market purchase +2,900 $3.76 $10,904
Mar 31, 2026 Nasus Pharma Ltd. Open-market purchase +15,000 $2.04 $30,600

Questions about Dan Benjamin Teleman

What boards is Dan Benjamin Teleman on?

Dan Benjamin Teleman sits on the board of Nasus Pharma Ltd.

Has Dan Benjamin Teleman been a CEO?

Yes — Dan Benjamin Teleman was CEO of Nasus Pharma Ltd. (2026 – 2026).

How long has Dan Benjamin Teleman served on boards?

Our records show at least 7 months of board service across 1 board, the earliest from 2026.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.